Immune Thrombocytopenia (ITP): Current Limitations in Patient Management

Primary immune thrombocytopenia (ITP) is an acquired autoimmune disorder characterized by isolated thrombocytopenia caused by increased platelet destruction and impaired platelet production. First-line therapies include corticosteroids, intravenous immunoglobulin, and anti-D immunoglobulin. For pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Terrell, Deirdra R., Neunert, Cindy E., Cooper, Nichola, Heitink-Pollé, Katja M., Kruse, Caroline, Imbach, Paul, Kühne, Thomas, Ghanima, Waleed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761470/
https://www.ncbi.nlm.nih.gov/pubmed/33266286
http://dx.doi.org/10.3390/medicina56120667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761470/
https://www.ncbi.nlm.nih.gov/pubmed/33266286
http://dx.doi.org/10.3390/medicina56120667

Ejemplares similares